June 18, 2026 · Form 4 insider transaction
FOUSE JACQUALYN A bought 2,927 shares of Agios Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.; The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested.